These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25740677)

  • 1. Pharmacokinetics of linezolid treatment using intravenous and oral administrations in extremely premature infants.
    Sicard M; Launay E; Caillon J; Jacqueline C; Legrand A; Deslandes G; Navas D; Rozé JC; Guen CG
    Eur J Clin Pharmacol; 2015 May; 71(5):611-5. PubMed ID: 25740677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of linezolid versus vancomycin as definitive antibiotic therapy for heterogeneously resistant vancomycin-intermediate coagulase-negative staphylococcal central-line-associated bloodstream infections in a neonatal intensive care unit.
    Blanchard AC; Fortin E; Laferrière C; Goyer I; Moussa A; Autmizguine J; Quach C
    J Antimicrob Chemother; 2017 Jun; 72(6):1812-1817. PubMed ID: 28333257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal and Neurodevelopmental Outcomes Following Linezolid for Coagulase-negative Staphylococcal Infection: Real World Evidence.
    Sicard M; Moussa A; Barrington K; Martin B; Luu TM; Ting JY; Roberts A; Paquette V; Shah PS; Kelly E; Autmizguine J
    Pediatr Infect Dis J; 2020 Jul; 39(7):598-603. PubMed ID: 32091496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Rodríguez-Vidigal FF; Vera Tomé A; Robles Marcos M
    Rev Esp Quimioter; 2011 Jun; 24(2):74-8. PubMed ID: 21666998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of application of vancomycin in the early stage of patients with extremely severe burn].
    Zhu Z; Cao GW; Bao JJ; Hu ZH; Shen Z; Tao H; Cao B; Xu F
    Zhonghua Shao Shang Za Zhi; 2017 Apr; 33(4):206-210. PubMed ID: 28427133
    [No Abstract]   [Full Text] [Related]  

  • 8. Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
    Pinheiro L; Brito CI; Pereira VC; Oliveira A; Bartolomeu AR; Camargo CH; Cunha ML
    Microb Drug Resist; 2016 Jun; 22(4):283-93. PubMed ID: 26623676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring.
    Ashizawa N; Tsuji Y; Kawago K; Higashi Y; Tashiro M; Nogami M; Gejo R; Narukawa M; Kimura T; Yamamoto Y
    J Infect Chemother; 2016 May; 22(5):331-4. PubMed ID: 26732509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid-Resistant Methicillin-Resistant Staphylococcus HemolyticusIsolated from Leukemic Patient: First Case Report from Pakistan.
    Gardezi A; Ikram A; Zaman G; Satti L; Ahmed P; Ayyub M
    J Coll Physicians Surg Pak; 2017 Sep; 27(9):S98-S100. PubMed ID: 28969738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
    Bergeret M; Boutros N; Raymond J
    Int J Antimicrob Agents; 2004 Mar; 23(3):247-53. PubMed ID: 15164965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal infections in infants: updates and current challenges.
    Blanchard AC; Quach C; Autmizguine J
    Clin Perinatol; 2015 Mar; 42(1):119-32, ix. PubMed ID: 25678000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections.
    Decousser JW; Desroches M; Bourgeois-Nicolaos N; Potier J; Jehl F; Lina G; Cattoir V; Vandenesh F; Doucet-Populaire F;
    Int J Antimicrob Agents; 2015 Dec; 46(6):622-30. PubMed ID: 26453147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid-resistant Staphylococcus epidermidis associated with long-term, repeated linezolid use in a pediatric patient.
    Ishiwada N; Takaya A; Kimura A; Watanabe M; Hino M; Ochiai H; Matsui M; Shibayama K; Yamamoto T
    J Infect Chemother; 2016 Mar; 22(3):187-90. PubMed ID: 26603427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetics of Intravenous Linezolid in Premature Infants.
    Thibault C; Kassir N; Goyer I; Théorêt Y; Litalien C; Moussa A; Ovetchkine P; Autmizguine J
    Pediatr Infect Dis J; 2019 Jan; 38(1):82-88. PubMed ID: 29634620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid in the treatment of periprosthetic joint infection caused by coagulase-negative staphylococci.
    Eriksson HK; Ahadpour D; Hailer NP; Lazarinis S; Järhult JD
    Infect Dis (Lond); 2019 Sep; 51(9):683-690. PubMed ID: 31389725
    [No Abstract]   [Full Text] [Related]  

  • 17. Linezolid Resistance in Staphylococcus haemolyticus - Case Series and Review of Literature.
    Gupta V; Gulati N; Sharma S; Gupta R; Soni A; Chander J
    Infect Disord Drug Targets; 2020; 20(5):713-717. PubMed ID: 31389316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoid Staphylococcus haemolyticus: an unheeded multidrug-resistant pathogen.
    Singhal L; Gupta V; Sharma S; Agarwal A; Gupta P
    Braz J Microbiol; 2023 Mar; 54(1):191-198. PubMed ID: 36680660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventive antibiotic administration for prevention of nosocomial septicemia in very small premature infants (VLBW infants)--preventive vancomycin administration against infections with coagulase negative streptococci--prevention of translocation with oral cefixime therapy in intestinal colonization with pathogenic gram-negative pathogens].
    Möller JC; Rossa M; Nachtrodt G; Richter A; Tegtmeyer FK
    Klin Padiatr; 1993; 205(3):140-4. PubMed ID: 8350584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The first experience with linezolide in treatment of nosocomial septic condition in premature neonates].
    Miletín J; Melichar J; Janota J; Mikolágová B; Jedlicková A; Kucera J; Cunát V; Stranák Z
    Ceska Gynekol; 2004 Dec; 69 Suppl 1():102-4. PubMed ID: 15748035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.